Lauren Schmitt is a clinical psychologist and translational researcher focused on the identification of brain-based biomarkers to inform the mechanistic understanding and treatment development in Fragile X Syndrome (FXS). She has been working at the Cincinnati Fragile X Research and Treatment Center for 7 years and has been recently been named the Director of Translational Research and Engagement. Her funding covers a diverse range of research projects including establishing the clinical utility of the molecular assays in FXS, conducting focus groups and qualitative analysis to develop a new parent-report measure of behavioral flexibility in FXS, and evaluating outcomes using her novel cognitive paradigm in the context of single-dose trials in FXS. Dr. Schmitt is actively involved in the FXS community, including participating in Advocacy Day in DC, hosting the bi-annual Cincinnati Fragile X Family Conference and annual Family Picnic, and working with NFXF on the Belongingness Project.